✦ LIBER ✦

MULTINOMIAL PHASE II CANCER TRIALS INCORPORATING RESPONSE AND EARLY PROGRESSION

✍ Scribed by Zee, Benny; Melnychuk, David; Dancey, Janet; Eisenhauer, Elizabeth

Book ID: 126572655
Publisher: Taylor and Francis Group
Year: 1999
Tongue: English
Weight: 143 KB
Volume: 9
Category: Article
ISSN: 1054-3406
DOI: 10.1081/BIP-100101181

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A80 Design of Phase II clinical trials i

A80 Design of Phase II clinical trials incorporating response and early progression

✍ Benny Zee; David Melnychuk; Janet Dancey; Elizabeth Eisenhauer 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Phase II Trial of Vinorelbine in Recurre

Phase II Trial of Vinorelbine in Recurrent and Progressive Epithelial Ovarian Cancer

✍ Robert A. Burger; Philip J. DiSaia; James A. Roberts; Mark O'Rourke; David M. Ge 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Flexible bivariate phase II clinical tri

Flexible bivariate phase II clinical trial design incorporating toxicity and response on different schedules

✍ Ray, Herman E.; Rai, Shesh N. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 915 KB

Response of patients in phase II studies

Response of patients in phase II studies of chemotherapy in ovarian cancer: implications for patient treatment and the design of phase II trials

✍ Blackledge, G; Lawton, F; Redman, C; Kelly, K 📂 Article 📅 1989 🏛 Nature Publishing Group 🌐 English ⚖ 604 KB

Association of pegylated liposomal doxor

Association of pegylated liposomal doxorubicin and ifosfamide in early recurrent ovarian cancer patients: A Multicenter Phase II Trial

✍ Florence Joly; Emmanuel Sevin; Alain Lortholary; Frank Priou; J.F. Paitel; Miche 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 299 KB

Phase II trial of irinotecan and cisplat

Phase II trial of irinotecan and cisplatin with early concurrent radiotherapy in limited-disease small-cell lung cancer

✍ Joo Hyuk Sohn; Yong Wha Moon; Chang Geol Lee; Gwi Eon Kim; Kyung Young Chung; Jo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

## Abstract ## BACKGROUND. A Phase II trial of irinotecan and cisplatin (IP) with early concurrent radiotherapy was performed in limited‐disease small‐cell lung cancer (LD‐SCLC) to evaluate the efficacy and toxicity. ## METHODS. For untreated LD‐SCLC patients, irinotecan (60 mg/m^2^, Days 1, 8,